Literature DB >> 30797441

Association between atrial fibrillation and right-sided manifestations of congestive heart failure in dogs with degenerative mitral valve disease or dilated cardiomyopathy.

Jessica Ward1, Wendy Ware2, Austin Viall3.   

Abstract

INTRODUCTION: To determine whether dogs with atrial fibrillation (AF) are more likely to develop right-sided manifestations of congestive heart failure (R-CHF) than dogs without AF. ANIMALS: Two hundred twenty dogs diagnosed with congestive heart failure (CHF) secondary to degenerative mitral valve disease (DMVD, n = 155) or dilated cardiomyopathy (DCM, n = 65) at a referral institution.
METHODS: Medical records were reviewed to extract relevant clinical and echocardiographic data.
RESULTS: Fifty dogs had AF at the time of CHF diagnosis, including 17/155 (11.0%) dogs with DMVD and 33/65 (50.8%) dogs with DCM. Sixty dogs had R-CHF evidenced by cavitary effusions. Among DMVD dogs, R-CHF occurred in 13/17 (76.5%) dogs with AF compared with 10/138 (7.2%) dogs without AF; among DCM dogs, R-CHF occurred in 24/33 (72.7%) dogs with AF compared with 13/32 (40.6%) dogs without AF. Dogs with AF were more likely to manifest R-CHF signs than dogs without AF (p < 0.0001 for DMVD; p = 0.0125 for DCM). The presence of AF, diagnosis of DCM, and moderate to severe tricuspid regurgitation were associated with R-CHF in multivariate analysis. AF was the strongest predictor of R-CHF (odds ratio, 14.44; 95% confidence interval, 5.75-36.26).
CONCLUSIONS: Dogs with AF are more likely to manifest R-CHF than dogs without AF. Cavitary effusions are an expected finding in approximately three-quarters of dogs with AF and CHF secondary to either DCM or DMVD.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arrhythmia; Ascites; Canine; Heart disease; Pleural effusion

Mesh:

Year:  2018        PMID: 30797441     DOI: 10.1016/j.jvc.2018.10.006

Source DB:  PubMed          Journal:  J Vet Cardiol        ISSN: 1760-2734            Impact factor:   1.701


  3 in total

1.  Serum digoxin concentrations in dogs with atrial fibrillation under long term digoxin treatment.

Authors:  Antonella Colella; Serena Digiaro; Marco Fiorentino; Beatrice Greco; Mariateresa Sasanelli; Paola Paradies
Journal:  Open Vet J       Date:  2022-06-03

2.  Factors related to survival time in dogs with pulmonary hypertension secondary to degenerative mitral valve disease stage C.

Authors:  Jutamas Udomkiattikul; Noppasorn Kirdratanasak; Panatsada Siritianwanitchakul; Wasaporn Worapunyaanun; Sirilak Disatian Surachetpong
Journal:  Int J Vet Sci Med       Date:  2022-04-29

3.  Prevalence and risk factors for atrial fibrillation in dogs with myxomatous mitral valve disease.

Authors:  Carlo Guglielmini; Marlos Goncalves Sousa; Marco Baron Toaldo; Carlotta Valente; Vinicius Bentivoglio; Chiara Mazzoldi; Ilaria Bergamin; Michele Drigo; Helen Poser
Journal:  J Vet Intern Med       Date:  2020-10-08       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.